{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:22:44Z","timestamp":1790749364573,"version":"4.1.0"},"reference-count":97,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec id=\"S2056472420000435_sec_a1\" sec-type=\"other\">\n\t    <jats:title>Background<\/jats:title>\n\t    <jats:p>Mood disorders, i.e. major depressive disorder (MDD) and bipolar disorders, are leading sources of disability worldwide. Currently available treatments do not yield remission in approximately a third of patients with a mood disorder. This is in part because these treatments do not target a specific core pathology underlying these heterogeneous disorders. In recent years, abnormal inflammatory processes have been identified as putative pathophysiological mechanisms and treatment targets in mood disorders, particularly among individuals with treatment-resistant conditions.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2056472420000435_sec_a2\" sec-type=\"other\">\n\t    <jats:title>Aims<\/jats:title>\n\t    <jats:p>In this selective review, we aimed to summarise recent advances in the field of immunopsychiatry, including emerging pathophysiological models and findings from treatment ttrials of immunomodulatory agents for both MDD and bipolar disorders.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2056472420000435_sec_a3\" sec-type=\"methods\">\n\t    <jats:title>Method<\/jats:title>\n\t    <jats:p>We performed a literature review by searching Medline for clinical trials of immunomodulating agents as monotherapy or adjunctive treatments in MDD and bipolar disorders. Included studies are randomised controlled trials (RCTs), cluster RCTs or cross-over trials of immunomodulating agents that had an active comparator or a placebo-arm.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2056472420000435_sec_a4\" sec-type=\"results\">\n\t    <jats:title>Results<\/jats:title>\n\t    <jats:p>Current evidence shows an association between inflammation and mood symptoms. However, there is conflicting evidence on whether this link is causal.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2056472420000435_sec_a5\" sec-type=\"conclusions\">\n\t    <jats:title>Conclusions<\/jats:title>\n\t    <jats:p>Future studies should focus on identifying specific neurobiological underpinnings for the putative causal association between an activated inflammatory response and mood disorders. Results of these studies are needed before further treatment trials of immunomodulatory agents can be justified.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1192\/bjo.2020.43","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:19:23Z","timestamp":1591341563000},"source":"Crossref","is-referenced-by-count":99,"title":["Inflammation as a treatment target in mood disorders: review"],"prefix":"10.1192","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-1059","authenticated-orcid":false,"given":"Brett D. M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-1124","authenticated-orcid":false,"given":"Rebecca","family":"Strawbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-6952","authenticated-orcid":false,"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ishrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"S2056472420000435_ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0448-7"},{"key":"S2056472420000435_ref30","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719001454"},{"key":"S2056472420000435_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.09.002"},{"key":"S2056472420000435_ref41","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000229"},{"key":"S2056472420000435_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.06.015"},{"key":"S2056472420000435_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2017.03.018"},{"key":"S2056472420000435_ref57","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2007.S110"},{"key":"S2056472420000435_ref74","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320912"},{"key":"S2056472420000435_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.06.016"},{"key":"S2056472420000435_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.11.007"},{"key":"S2056472420000435_ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.12.067"},{"key":"S2056472420000435_ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0474-5"},{"key":"S2056472420000435_ref2","volume-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"S2056472420000435_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.01.015"},{"key":"S2056472420000435_ref75","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13016"},{"key":"S2056472420000435_ref29","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12698"},{"key":"S2056472420000435_ref28","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.233"},{"key":"S2056472420000435_ref47","doi-asserted-by":"publisher","DOI":"10.1177\/1536012118792317"},{"key":"S2056472420000435_ref26","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.167"},{"key":"S2056472420000435_ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117725711"},{"key":"S2056472420000435_ref25","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000020509.23162.cc"},{"key":"S2056472420000435_ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13666150630175044"},{"key":"S2056472420000435_ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1611"},{"key":"S2056472420000435_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.02.013"},{"key":"S2056472420000435_ref4","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S114542"},{"key":"S2056472420000435_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.05.010"},{"key":"S2056472420000435_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.01.014"},{"key":"S2056472420000435_ref18","year":"1992","journal-title":"The ICD-10 Classification of Mental and Behavioural Disorders Clinical Descriptions and Diagnostic Guidelines."},{"key":"S2056472420000435_ref78","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i25.2764"},{"key":"S2056472420000435_ref8","volume-title":"Antidepressants: From Biogenic Amines to New Mechanisms of Action","author":"Macaluso","year":"2018"},{"key":"S2056472420000435_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2401"},{"key":"S2056472420000435_ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3943-9"},{"key":"S2056472420000435_ref90","doi-asserted-by":"publisher","DOI":"10.1002\/da.22601"},{"key":"S2056472420000435_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.10.001"},{"key":"S2056472420000435_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.09.016"},{"key":"S2056472420000435_ref95","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0096-3"},{"key":"S2056472420000435_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12373"},{"key":"S2056472420000435_ref1","volume-title":"WHO Global Burden of Disease (2008): 2004 Update","year":"2008"},{"key":"S2056472420000435_ref35","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003038"},{"key":"S2056472420000435_ref31","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"K\u00f6hler","year":"2018","journal-title":"Mol Neurobiol"},{"key":"S2056472420000435_ref3","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1211"},{"key":"S2056472420000435_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.12.015"},{"key":"S2056472420000435_ref84","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S115002"},{"key":"S2056472420000435_ref9","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X675430"},{"key":"S2056472420000435_ref71","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12862"},{"key":"S2056472420000435_ref19","volume-title":"User Guide for the Structural Clinical Interview for DSM-IV Axis I Disorders. APA","author":"First","year":"1996"},{"key":"S2056472420000435_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79625-2"},{"key":"S2056472420000435_ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"S2056472420000435_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.12.059"},{"key":"S2056472420000435_ref93","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12983"},{"key":"S2056472420000435_ref83","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0073-7"},{"key":"S2056472420000435_ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09091379"},{"key":"S2056472420000435_ref61","first-page":"891","article-title":"A randomized, doubleblind, placebo-controlled trial of celecoxib augmentation of sertraline in treatment of drug-naive depressed women: a pilot study","volume":"14","author":"Majd","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"S2056472420000435_ref20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"key":"S2056472420000435_ref97","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0561-y"},{"key":"S2056472420000435_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(88)80004-6"},{"key":"S2056472420000435_ref48","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.5"},{"key":"S2056472420000435_ref89","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0779"},{"key":"S2056472420000435_ref49","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"Bin","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"S2056472420000435_ref50","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2009.116"},{"key":"S2056472420000435_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12211"},{"key":"S2056472420000435_ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.12.017"},{"key":"S2056472420000435_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(01)00133-4"},{"key":"S2056472420000435_ref53","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21325"},{"key":"S2056472420000435_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(91)90272-Z"},{"key":"S2056472420000435_ref54","doi-asserted-by":"publisher","DOI":"10.1038\/nn835"},{"key":"S2056472420000435_ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2012.07.026"},{"key":"S2056472420000435_ref56","doi-asserted-by":"publisher","DOI":"10.1021\/tx700248y"},{"key":"S2056472420000435_ref59","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001805"},{"key":"S2056472420000435_ref81","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12496"},{"key":"S2056472420000435_ref60","doi-asserted-by":"publisher","DOI":"10.1002\/da.20589"},{"key":"S2056472420000435_ref63","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.167"},{"key":"S2056472420000435_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"S2056472420000435_ref64","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamapsychiatry.4"},{"key":"S2056472420000435_ref39","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12414"},{"key":"S2056472420000435_ref66","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000098"},{"key":"S2056472420000435_ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.02.002"},{"key":"S2056472420000435_ref68","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117724352"},{"key":"S2056472420000435_ref69","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417709357"},{"key":"S2056472420000435_ref7","doi-asserted-by":"publisher","DOI":"10.1177\/070674371405900702"},{"key":"S2056472420000435_ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.10.042"},{"key":"S2056472420000435_ref72","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08454"},{"key":"S2056472420000435_ref76","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09300"},{"key":"S2056472420000435_ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.07.003"},{"key":"S2056472420000435_ref11","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7110144"},{"key":"S2056472420000435_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.03.033"},{"key":"S2056472420000435_ref79","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000457"},{"key":"S2056472420000435_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.03.016"},{"key":"S2056472420000435_ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.04.022"},{"key":"S2056472420000435_ref86","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1257-1"},{"key":"S2056472420000435_ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.10.083"},{"key":"S2056472420000435_ref88","first-page":"1","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"S2056472420000435_ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.02.056"},{"key":"S2056472420000435_ref91","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.66"},{"key":"S2056472420000435_ref92","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00458"},{"key":"S2056472420000435_ref94","article-title":"Peripheral blood cell\u2013stratified subgroups of inflamed depression","author":"Lynall","journal-title":"Biol Psychiatry"},{"key":"S2056472420000435_ref96","article-title":"Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states","author":"Simmons","journal-title":"Mol Psychiatry"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472420000435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:19:29Z","timestamp":1591341569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472420000435\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":97,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["S2056472420000435"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2020.43","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"article-number":"e60"}}